Living with Bladder Pain and Discomfort?

Learn more about the OAG1050 Study for interstitial cystitis (IC) and bladder pain syndrome (BPS).

Study Seeking Patients

Living With Bladder Pain and Discomfort?
Learn more about the OAG1050 Study for interstitial cystitis (IC) and bladder pain syndrome (BPS).

If symptoms of interstitial cystitis or bladder pain – like urinary problems or discomfort - impact everyday activities, you may qualify for a study.

The OAG1050 study is testing an investigational medication that is designed to help alleviate the symptoms of IC/BPS. The investigational medication is a tablet taken once daily before bed.

You may be able to join this study if you:

  • Are a female between 18 and 70 years of age
  • Have been diagnosed with interstitial cystitis or bladder pain syndrome or have been experiencing bladder pain, pressure or discomfort accompanied by a frequent need for urination that is not due to other causes (e.g., infection) and has persisted for at least 6 months
  • Are willing to travel to the clinic up to 9 times during an 8-week study treatment period
  • Are willing to use a computer or cell phone (can be your personal device) to monitor and record information daily about your pattern of pain and urination for the duration of the study

There are other requirements for taking part in the OAG1050 study. The study team will discuss additional study requirements, procedures, and your rights and responsibilities   with you.

Participation in the OAG1050 study lasts approximately 3.5 months and requires up to 9 visits to the study site and at least 4 phone calls plus daily recording of your symptoms using an app on your cell phone or other device.

If you qualify, you will receive - at no cost -access to the investigational medication, careful evaluation and frequent monitoring of your condition, and the opportunity to help advance the treatment of interstitial cystitis and bladder pain syndrome. Reimbursement may be available for study-related time and travel expenses.

Please click to visit our website and see if you may be eligible for the OAG1050 study.

The Interstitial Cystitis Association (ICA) advocates for interstitial cystitis/bladder pain syndrome (IC/BPS) research dedicated to discovery of a cure and better treatments, raises awareness, and serves as a central hub for the healthcare providers, researchers and millions of patients who suffer with constant urinary urgency and frequency and extreme bladder pain called IC/BPS. 

ICA is providing this information as a service and is neither sponsoring nor conducting this research study. ICA does not have any participation in determining the acceptance criteria or in selecting study participants. ICA’s sole intent is to make potentially eligible participants aware of this study. Should you have any questions regarding the study, please contact the study coordinator directly.